March 1, 2018 / 9:07 PM / 6 months ago

BRIEF-MannKind Opens Enrollment Of Phase 1 Trial Of Treprostinil Technosphere

March 1 (Reuters) - Mannkind Corp:

* MANNKIND OPENS ENROLLMENT OF PHASE 1 TRIAL OF TREPROSTINIL TECHNOSPHERE FOR PULMONARY ARTERIAL HYPERTENSION

* MANNKIND - IF SUCCESSFUL, PHASE 1 STUDY OF TREPROSTINIL TECHNOSPHERE FOR PULMONARY ARTERIAL HYPERTENSION WILL LEAD TO REGISTRATION STUDIES IN 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below